RxDoctor Payments Data

Cecily Havert, MD

Family Medicine · Arlington, VANPI 1700998309

Payments from drug & device makers

$2,560in general payments, 2019–2025

Across 119 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$539
  • Amgen$492
  • AbbVie$285
  • Lilly USA, LLC$263
  • Pfizer$231
  • Gilead$185
  • plus $564 from 16 others

What the payments were for

  • Food & beverage$2,560100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,560 in reported general payments places this provider in the 80th percentile of 2,553 family medicine providers in Virginia.

See all family medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$101,581
Medicare patients
121
Services billed
1,929

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$52,198
BriviactBrivaracetam11$15,892
EliquisApixaban16$4,755
SynthroidLevothyroxine Sodium50$3,876
Eletriptan HbrEletriptan Hydrobromide13$1,758
Celecoxib15$1,488
Levothyroxine Sodium58$937
Atorvastatin Calcium78$847
Morphine Sulfate ErMorphine Sulfate23$822
Sertraline Hcl54$726
Lisinopril53$617
Rosuvastatin Calcium43$531
Allopurinol19$509
Memantine Hcl21$505
Esomeprazole Magnesium13$437

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$539$52,19839 claims
UCB, Inc.Briviact$26$15,89211 claims
PfizerEliquis$231$4,75516 claims
AbbVieSynthroid$285$3,87650 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,553 family medicine providers in Virginia.

Other family medicine in Arlington

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →